Protein-Drug Conjugates

Target Class

Undisclosed

Modality

Protein drug conjugate

Descriptor

Innovative non-antibody toxin conjugated drug scaffold

Status

Almac’s site specific protein labelling technology is being used in conjunction with a shark VNAR/soloMERTM platform to develop a next generation protein drug conjugate.

For more information click here.